GE HealthCare and private hospital group Swiss Medical Network have agreed to establish a molecular imaging and theranostics center of excellence at Clinique de Genolier, located 25 km from Geneva and 35 km from Lausanne.
The vendor and network have signed an agreement under which GE will provide equipment, access to proprietary tools and technologies, and support for research projects at Clinique de Genolier. The deal follows a strategic cooperation agreement signed in 2022 and will advance precision medicine and theranostics, a cornerstone of precision oncology, the firm said.
"The agility of the Swiss Medical Network enables us to rapidly validate and adopt innovative technologies, including AI-driven capabilities, and advance the future of healthcare," stated GE HealthCare President and CEO Peter Arduini in the announcement.
Swiss Medical Network has transformed its nuclear medicine platform, relocating to a new facility at Genolier and a new facility in Clinique Générale Beaulieu, Lake Geneva Area, the firm added. This includes the adoption of GE HealthCare’s imaging and analysis technologies, including Omni Legend 32 PET/CT system, StarGuide advanced SPECT/CT system, and 870DR general purpose SPECT/CT unit.
